Immediate Impact

2 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
3 intermediate papers

Works of Jay Duffner being referenced

M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study
2018
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
2016

Author Peers

Author Last Decade Papers Cites
Jay Duffner 123 80 132 17 332
Tanja Gerlza 99 31 105 24 340
Elisabeth Mbemba 138 15 79 26 355
Sara E. Vazquez 100 59 132 18 367
B. Mennesson 246 41 90 12 369
Kazuhiro Yago 134 59 72 27 281
Yukai Jing 105 25 178 26 328
Darren R. Jones 98 50 118 15 282
George L. Manderino 148 57 74 24 362
M Stempniak 152 123 137 10 351
P. M�ller 126 51 77 14 349

All Works

Loading papers...

Rankless by CCL
2026